Astrup, T.: The biological significance of fibrinolysis. Lancet , 2: 565, 1956.
3.
Merskey, C., Gordon, H., Lackner, H., Schrire, V., Kaplan, B.J., Sougin-Mibo-Shan, R., Hossel, H.B., AND Moodie, A.: Blood coagulation and fibrinolysis in relation to coronary heart disease . Brit. M. J., 1: 219, 1960.
4.
Norman, P.S. : Studies of the plasmin system. I. Measurement of human and animal plasminogen. Measurement of an activator in human serum . J. Exper. Med., 106: 423, 1957.
5.
Norman, P.S. : Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma. J. Exper. Med., 108; 53, 1958.
6.
Milstone, H. : A factor in normal human blood which participates in streptococcal fibrinolysin. J. Immunol., 42: 109, 1941.
7.
Sawyer, W.D. , Fletcher, A.P., Alkjoersig , N., AND Sherry, S.: Studies on the thrombolytic activity of human plasma. J. Clin. Invest., 39: 426, 1960.
8.
Sherry, S., Fletcher, A.P., AND Alkjoersig, N.: Fibrinolysis and fibrinolytic activity in man. Physiol. Rev. , 39: 343, 1959.
9.
Reugsegger, P., Nydick, I., Hutter , R.C., Freiman, A.H., Bang, N.H., Cliffton, E.E., AND Ladue, J.S.: Fibrinolytic (plasmin) therapy of experimental coronary thrombi with alteration of the evolution of myocardial infarction . Circulation, 19: 7, 1959.
